Skip to main content

The Lancet Oncology

  • ISSN: 1470-2045

Next planned ship date: April 29, 2024

  • 5 Year impact factor: 46.1
  • Impact factor: 51.1

The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), review… Read more

Subscription options

Next planned ship date:
April 29, 2024

Institutional subscription on ScienceDirect

Request a sales quote
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to clinical cancer specialties worldwide. Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology.